Growth factor binding to the pericellular matrix and its importance in tissue engineering

被引:224
作者
Macri, Lauren [1 ]
Silverstein, David [2 ]
Clark, Richard A. F. [1 ,3 ,4 ]
机构
[1] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA
[3] SUNY Stony Brook, Dept Dermatol, Stony Brook, NY 11794 USA
[4] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA
关键词
pericellular matrix; extracellular matrix; tissue engineering; growth factor; cytokine; growth factor binding;
D O I
10.1016/j.addr.2007.08.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In addition to its typical role as a scaffold, molecular filter, and cell modulator, the pericellular matrix can bind bioactive molecules and serve as a repository, while regulating their activation, synthesis, and degradation. This review focuses on interactions between bioactives, specifically growth factors and cytokines, with various components of the pericellular matrix. For example, biglycan and betaglycan, proteoglycans of the pericellualar matrix, and decorin, a proteoglycan of the interstitial extracellular matrix, bind and regulate the activity and availability of transforming growth factor-beta. From evidence presented in this paper, it is obvious that the presence of growth factors in the pericellular matrix is integral to the spatiotemporal coordination of cellular activities to ensure proper tissue/organ formation during wound healing. It is believed by many researchers that the delivery of the right growth factors at the right time is instrumental to the orchestration of tissue regeneration. Thus, the interplay between the pericellular environment and bioactive molecules provides an underutilized knowledge base in the design and creation of tissue engineered constructs. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:1366 / 1381
页数:16
相关论文
共 178 条
[1]  
Abraham J. A., 1996, MOL CELLULAR BIOL WO, P195
[2]  
ALON R, 1994, J IMMUNOL, V152, P1304
[3]   Mice deficient in small leucine-rich proteoglycans:: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases [J].
Ameye, L ;
Young, MF .
GLYCOBIOLOGY, 2002, 12 (09) :107R-116R
[4]   The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety [J].
Aspberg, A ;
Miura, R ;
Bourdoulous, S ;
Shimonaka, M ;
Heinegard, D ;
Schachner, M ;
Ruoslahti, E ;
Yamaguchi, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) :10116-10121
[5]   SPECIFIC-INHIBITION OF ENDOTHELIAL-CELL PROLIFERATION BY THROMBOSPONDIN [J].
BAGAVANDOSS, P ;
WILKS, JW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 170 (02) :867-872
[6]   LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan [J].
Banerji, S ;
Ni, J ;
Wang, SX ;
Clasper, S ;
Su, J ;
Tammi, R ;
Jones, M ;
Jackson, DG .
JOURNAL OF CELL BIOLOGY, 1999, 144 (04) :789-801
[7]   THE CELL BIOLOGY OF TRANSFORMING GROWTH-FACTOR-BETA [J].
BARNARD, JA ;
LYONS, RM ;
MOSES, HL .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1032 (01) :79-87
[8]   THE FGF FAMILY OF GROWTH-FACTORS AND ONCOGENES [J].
BASILICO, C ;
MOSCATELLI, D .
ADVANCES IN CANCER RESEARCH, 1992, 59 :115-165
[9]  
BENTLEY JP, 1967, ANN SURG, V165, P186
[10]   Heparan sulphate proteoglycans fine-tune mammalian physiology [J].
Bishop, Joseph R. ;
Schuksz, Manuela ;
Esko, Jeffrey D. .
NATURE, 2007, 446 (7139) :1030-1037